Kidney Injury After PTE: Association With Hypothermic Circulatory Arrest Duration
NCT ID: NCT07132619
Last Updated: 2025-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2024-06-30
2025-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk of Acute Kidney Injury in Pulmonary Endarterectomy
NCT07135206
Renal Oxygen Saturation and Its Association With Acute Renal Injury
NCT03608956
The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria
NCT03675906
Evaluation of Postoperative Acute Kidney Injury (AKI) Incidence and Risk Factors in Patients Underwent Pneumonectomy
NCT05672238
Assessment of Acute Kidney Injury as a Risk Factor for Myocardial Injury After Non Cardiac Surgery in Critical Patients
NCT03135483
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines emphasize the use of both biomarkers in AKI diagnosis, yet most studies rely solely on creatinine. Given the limitations of isolated creatinine-based assessment, integrating hourly urine output offers a more comprehensive understanding of renal function. This study was designed to evaluate the relationship between TCA duration and the incidence and severity of AKI in patients undergoing PEA, using full KDIGO 2012 criteria. The goal was to better characterize AKI risk in this high-acuity population and inform perioperative management strategies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Underwent pulmonary endarterectomy between 2018 and 2020
Exclusion Criteria
* Pregnant women
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ebru Girgin Dinc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ebru Girgin Dinc
M.D., Anesthesiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Atakan ERKILINC, MD, Associate Professor
Role: PRINCIPAL_INVESTIGATOR
University of Health Sciences, Kosuyolu Heart Training and Research Hospital, Kartal, ISTANBUL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kosuyolu Heart Training and Research Hospital
Istanbul, Kartal, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HTCA-PEA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.